nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—Brain neoplasm—Carmustine—malignant glioma	0.0465	0.0962	CcSEcCtD
Morphine—Disease progression—Carmustine—malignant glioma	0.0201	0.0415	CcSEcCtD
Morphine—OPRM1—telencephalic ventricle—malignant glioma	0.0127	0.141	CbGeAlD
Morphine—Ethylmorphine—POR—malignant glioma	0.0114	0.573	CrCbGaD
Morphine—Intracranial pressure increased—Carmustine—malignant glioma	0.0105	0.0217	CcSEcCtD
Morphine—OPRL1—brainstem—malignant glioma	0.0098	0.109	CbGeAlD
Morphine—OPRL1—telencephalon—malignant glioma	0.0087	0.0965	CbGeAlD
Morphine—OPRL1—spinal cord—malignant glioma	0.00609	0.0676	CbGeAlD
Morphine—Lung disorder—Temozolomide—malignant glioma	0.00599	0.0124	CcSEcCtD
Morphine—Apathy—Temozolomide—malignant glioma	0.00593	0.0123	CcSEcCtD
Morphine—Flat affect—Temozolomide—malignant glioma	0.00588	0.0122	CcSEcCtD
Morphine—Stupor—Carmustine—malignant glioma	0.00588	0.0121	CcSEcCtD
Morphine—Hyperaesthesia—Temozolomide—malignant glioma	0.0054	0.0112	CcSEcCtD
Morphine—Injection site pain—Carmustine—malignant glioma	0.00537	0.0111	CcSEcCtD
Morphine—Rigors—Temozolomide—malignant glioma	0.00519	0.0107	CcSEcCtD
Morphine—Accidental injury—Carmustine—malignant glioma	0.00496	0.0102	CcSEcCtD
Morphine—OPRL1—central nervous system—malignant glioma	0.00494	0.0549	CbGeAlD
Morphine—Amenorrhoea—Temozolomide—malignant glioma	0.00482	0.00997	CcSEcCtD
Morphine—Thinking abnormal—Carmustine—malignant glioma	0.00479	0.00991	CcSEcCtD
Morphine—Drug interaction—Carmustine—malignant glioma	0.00473	0.00978	CcSEcCtD
Morphine—Gait disturbance—Carmustine—malignant glioma	0.00449	0.00929	CcSEcCtD
Morphine—OPRD1—telencephalon—malignant glioma	0.00448	0.0497	CbGeAlD
Morphine—Coordination abnormal—Carmustine—malignant glioma	0.00447	0.00923	CcSEcCtD
Morphine—Pulmonary embolism—Carmustine—malignant glioma	0.00439	0.00907	CcSEcCtD
Morphine—Gait disturbance—Temozolomide—malignant glioma	0.00434	0.00898	CcSEcCtD
Morphine—Coordination abnormal—Temozolomide—malignant glioma	0.00432	0.00892	CcSEcCtD
Morphine—Respiratory failure—Temozolomide—malignant glioma	0.00432	0.00892	CcSEcCtD
Morphine—Pulmonary embolism—Temozolomide—malignant glioma	0.00424	0.00876	CcSEcCtD
Morphine—Depressed level of consciousness—Carmustine—malignant glioma	0.00424	0.00876	CcSEcCtD
Morphine—Depressed level of consciousness—Temozolomide—malignant glioma	0.00409	0.00846	CcSEcCtD
Morphine—Ethylmorphine—CYP2B6—malignant glioma	0.00408	0.205	CrCbGaD
Morphine—Coma—Carmustine—malignant glioma	0.00401	0.00829	CcSEcCtD
Morphine—OPRL1—brain—malignant glioma	0.00393	0.0436	CbGeAlD
Morphine—Gynaecomastia—Carmustine—malignant glioma	0.00392	0.00811	CcSEcCtD
Morphine—Sepsis—Carmustine—malignant glioma	0.00381	0.00787	CcSEcCtD
Morphine—Mental disability—Carmustine—malignant glioma	0.00381	0.00787	CcSEcCtD
Morphine—Phlebitis—Carmustine—malignant glioma	0.0037	0.00764	CcSEcCtD
Morphine—Mental disability—Temozolomide—malignant glioma	0.00368	0.0076	CcSEcCtD
Morphine—Swelling—Carmustine—malignant glioma	0.00361	0.00746	CcSEcCtD
Morphine—Eye pain—Carmustine—malignant glioma	0.00353	0.00729	CcSEcCtD
Morphine—Gastroenteritis—Temozolomide—malignant glioma	0.00347	0.00718	CcSEcCtD
Morphine—Injury—Carmustine—malignant glioma	0.00346	0.00716	CcSEcCtD
Morphine—OPRM1—brainstem—malignant glioma	0.00344	0.0382	CbGeAlD
Morphine—Eye pain—Temozolomide—malignant glioma	0.00341	0.00705	CcSEcCtD
Morphine—Amnesia—Carmustine—malignant glioma	0.00339	0.00701	CcSEcCtD
Morphine—Amnesia—Temozolomide—malignant glioma	0.00328	0.00677	CcSEcCtD
Morphine—Thirst—Temozolomide—malignant glioma	0.00323	0.00668	CcSEcCtD
Morphine—Hyponatraemia—Carmustine—malignant glioma	0.0032	0.00661	CcSEcCtD
Morphine—Diplopia—Carmustine—malignant glioma	0.00318	0.00658	CcSEcCtD
Morphine—Diplopia—Temozolomide—malignant glioma	0.00308	0.00636	CcSEcCtD
Morphine—OPRM1—telencephalon—malignant glioma	0.00306	0.0339	CbGeAlD
Morphine—Affect lability—Temozolomide—malignant glioma	0.00303	0.00626	CcSEcCtD
Morphine—Ataxia—Carmustine—malignant glioma	0.00299	0.00619	CcSEcCtD
Morphine—Liver function test abnormal—Carmustine—malignant glioma	0.00294	0.00608	CcSEcCtD
Morphine—Mood swings—Temozolomide—malignant glioma	0.00291	0.00603	CcSEcCtD
Morphine—Hypokalaemia—Carmustine—malignant glioma	0.0029	0.00599	CcSEcCtD
Morphine—Ataxia—Temozolomide—malignant glioma	0.00289	0.00598	CcSEcCtD
Morphine—Dehydration—Temozolomide—malignant glioma	0.00286	0.00592	CcSEcCtD
Morphine—Dry skin—Temozolomide—malignant glioma	0.00282	0.00583	CcSEcCtD
Morphine—Hypokalaemia—Temozolomide—malignant glioma	0.0028	0.00579	CcSEcCtD
Morphine—Breast disorder—Temozolomide—malignant glioma	0.00278	0.00575	CcSEcCtD
Morphine—Dysphagia—Carmustine—malignant glioma	0.00275	0.00569	CcSEcCtD
Morphine—Abdominal distension—Temozolomide—malignant glioma	0.00268	0.00553	CcSEcCtD
Morphine—Dysphagia—Temozolomide—malignant glioma	0.00266	0.0055	CcSEcCtD
Morphine—Sweating increased—Temozolomide—malignant glioma	0.00259	0.00536	CcSEcCtD
Morphine—OPRD1—central nervous system—malignant glioma	0.00255	0.0283	CbGeAlD
Morphine—Dysuria—Temozolomide—malignant glioma	0.00249	0.00514	CcSEcCtD
Morphine—Hyperglycaemia—Carmustine—malignant glioma	0.00248	0.00513	CcSEcCtD
Morphine—Erectile dysfunction—Temozolomide—malignant glioma	0.00245	0.00506	CcSEcCtD
Morphine—OPRK1—central nervous system—malignant glioma	0.00244	0.0271	CbGeAlD
Morphine—Renal failure—Carmustine—malignant glioma	0.00241	0.00499	CcSEcCtD
Morphine—Galantamine—BCHE—malignant glioma	0.00241	0.121	CrCbGaD
Morphine—Weight decreased—Temozolomide—malignant glioma	0.00241	0.00497	CcSEcCtD
Morphine—Hyperglycaemia—Temozolomide—malignant glioma	0.0024	0.00496	CcSEcCtD
Morphine—Stomatitis—Carmustine—malignant glioma	0.00239	0.00494	CcSEcCtD
Morphine—OPRK1—cerebellum—malignant glioma	0.00239	0.0265	CbGeAlD
Morphine—Urinary tract infection—Carmustine—malignant glioma	0.00239	0.00493	CcSEcCtD
Morphine—Stomatitis—Temozolomide—malignant glioma	0.00231	0.00478	CcSEcCtD
Morphine—Urinary tract infection—Temozolomide—malignant glioma	0.0023	0.00477	CcSEcCtD
Morphine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00224	0.00464	CcSEcCtD
Morphine—OPRM1—midbrain—malignant glioma	0.00219	0.0244	CbGeAlD
Morphine—Hypoaesthesia—Carmustine—malignant glioma	0.00219	0.00453	CcSEcCtD
Morphine—Hallucination—Carmustine—malignant glioma	0.00219	0.00453	CcSEcCtD
Morphine—Oedema peripheral—Carmustine—malignant glioma	0.00217	0.00449	CcSEcCtD
Morphine—Connective tissue disorder—Carmustine—malignant glioma	0.00216	0.00448	CcSEcCtD
Morphine—OPRM1—spinal cord—malignant glioma	0.00214	0.0238	CbGeAlD
Morphine—Hepatitis—Temozolomide—malignant glioma	0.00213	0.0044	CcSEcCtD
Morphine—Visual impairment—Carmustine—malignant glioma	0.00212	0.00439	CcSEcCtD
Morphine—Hypoaesthesia—Temozolomide—malignant glioma	0.00212	0.00438	CcSEcCtD
Morphine—Hallucination—Temozolomide—malignant glioma	0.00212	0.00438	CcSEcCtD
Morphine—Urinary tract disorder—Temozolomide—malignant glioma	0.0021	0.00435	CcSEcCtD
Morphine—Oedema peripheral—Temozolomide—malignant glioma	0.0021	0.00434	CcSEcCtD
Morphine—Connective tissue disorder—Temozolomide—malignant glioma	0.00209	0.00432	CcSEcCtD
Morphine—Urethral disorder—Temozolomide—malignant glioma	0.00209	0.00431	CcSEcCtD
Morphine—Eye disorder—Carmustine—malignant glioma	0.00206	0.00426	CcSEcCtD
Morphine—Visual impairment—Temozolomide—malignant glioma	0.00205	0.00424	CcSEcCtD
Morphine—Flushing—Carmustine—malignant glioma	0.00204	0.00423	CcSEcCtD
Morphine—Hydromorphone—PTGS1—malignant glioma	0.00203	0.102	CrCbGaD
Morphine—OPRD1—brain—malignant glioma	0.00202	0.0224	CbGeAlD
Morphine—Eye disorder—Temozolomide—malignant glioma	0.00199	0.00411	CcSEcCtD
Morphine—Flushing—Temozolomide—malignant glioma	0.00198	0.00408	CcSEcCtD
Morphine—OPRK1—brain—malignant glioma	0.00194	0.0215	CbGeAlD
Morphine—Angiopathy—Temozolomide—malignant glioma	0.00193	0.00399	CcSEcCtD
Morphine—Mental disorder—Carmustine—malignant glioma	0.00193	0.00399	CcSEcCtD
Morphine—Mediastinal disorder—Temozolomide—malignant glioma	0.00192	0.00397	CcSEcCtD
Morphine—Malnutrition—Carmustine—malignant glioma	0.00192	0.00396	CcSEcCtD
Morphine—Erythema—Carmustine—malignant glioma	0.00192	0.00396	CcSEcCtD
Morphine—Chills—Temozolomide—malignant glioma	0.00191	0.00395	CcSEcCtD
Morphine—Mental disorder—Temozolomide—malignant glioma	0.00186	0.00386	CcSEcCtD
Morphine—Back pain—Carmustine—malignant glioma	0.00185	0.00383	CcSEcCtD
Morphine—Malnutrition—Temozolomide—malignant glioma	0.00185	0.00383	CcSEcCtD
Morphine—Erythema—Temozolomide—malignant glioma	0.00185	0.00383	CcSEcCtD
Morphine—ABCB1—blood vessel—malignant glioma	0.00182	0.0202	CbGeAlD
Morphine—Dysgeusia—Temozolomide—malignant glioma	0.00181	0.00375	CcSEcCtD
Morphine—Vision blurred—Carmustine—malignant glioma	0.00181	0.00374	CcSEcCtD
Morphine—Tremor—Carmustine—malignant glioma	0.0018	0.00371	CcSEcCtD
Morphine—Back pain—Temozolomide—malignant glioma	0.00179	0.00371	CcSEcCtD
Morphine—Anaemia—Carmustine—malignant glioma	0.00177	0.00366	CcSEcCtD
Morphine—Agitation—Carmustine—malignant glioma	0.00176	0.00364	CcSEcCtD
Morphine—Vision blurred—Temozolomide—malignant glioma	0.00175	0.00361	CcSEcCtD
Morphine—OPRM1—central nervous system—malignant glioma	0.00174	0.0193	CbGeAlD
Morphine—Tremor—Temozolomide—malignant glioma	0.00174	0.00359	CcSEcCtD
Morphine—Ill-defined disorder—Temozolomide—malignant glioma	0.00172	0.00355	CcSEcCtD
Morphine—Leukopenia—Carmustine—malignant glioma	0.00172	0.00355	CcSEcCtD
Morphine—Anaemia—Temozolomide—malignant glioma	0.00171	0.00354	CcSEcCtD
Morphine—Agitation—Temozolomide—malignant glioma	0.0017	0.00352	CcSEcCtD
Morphine—Malaise—Temozolomide—malignant glioma	0.00167	0.00345	CcSEcCtD
Morphine—Vertigo—Temozolomide—malignant glioma	0.00166	0.00344	CcSEcCtD
Morphine—Convulsion—Carmustine—malignant glioma	0.00166	0.00343	CcSEcCtD
Morphine—Leukopenia—Temozolomide—malignant glioma	0.00166	0.00343	CcSEcCtD
Morphine—Hypertension—Carmustine—malignant glioma	0.00166	0.00342	CcSEcCtD
Morphine—Palpitations—Temozolomide—malignant glioma	0.00164	0.00339	CcSEcCtD
Morphine—Chest pain—Carmustine—malignant glioma	0.00163	0.00337	CcSEcCtD
Morphine—Anxiety—Carmustine—malignant glioma	0.00163	0.00336	CcSEcCtD
Morphine—Cough—Temozolomide—malignant glioma	0.00162	0.00334	CcSEcCtD
Morphine—Convulsion—Temozolomide—malignant glioma	0.00161	0.00332	CcSEcCtD
Morphine—Hypertension—Temozolomide—malignant glioma	0.0016	0.00331	CcSEcCtD
Morphine—Confusional state—Carmustine—malignant glioma	0.00158	0.00326	CcSEcCtD
Morphine—Arthralgia—Temozolomide—malignant glioma	0.00158	0.00326	CcSEcCtD
Morphine—Anxiety—Temozolomide—malignant glioma	0.00157	0.00325	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00157	0.00324	CcSEcCtD
Morphine—Oedema—Carmustine—malignant glioma	0.00156	0.00324	CcSEcCtD
Morphine—Discomfort—Temozolomide—malignant glioma	0.00156	0.00322	CcSEcCtD
Morphine—Infection—Carmustine—malignant glioma	0.00155	0.00321	CcSEcCtD
Morphine—Dry mouth—Temozolomide—malignant glioma	0.00154	0.00319	CcSEcCtD
Morphine—Thrombocytopenia—Carmustine—malignant glioma	0.00153	0.00317	CcSEcCtD
Morphine—Tachycardia—Carmustine—malignant glioma	0.00153	0.00316	CcSEcCtD
Morphine—Confusional state—Temozolomide—malignant glioma	0.00152	0.00315	CcSEcCtD
Morphine—Oedema—Temozolomide—malignant glioma	0.00151	0.00313	CcSEcCtD
Morphine—Anaphylactic shock—Temozolomide—malignant glioma	0.00151	0.00313	CcSEcCtD
Morphine—Infection—Temozolomide—malignant glioma	0.0015	0.00311	CcSEcCtD
Morphine—Anorexia—Carmustine—malignant glioma	0.00149	0.00308	CcSEcCtD
Morphine—Nervous system disorder—Temozolomide—malignant glioma	0.00148	0.00307	CcSEcCtD
Morphine—Thrombocytopenia—Temozolomide—malignant glioma	0.00148	0.00306	CcSEcCtD
Morphine—Skin disorder—Temozolomide—malignant glioma	0.00147	0.00304	CcSEcCtD
Morphine—Hypotension—Carmustine—malignant glioma	0.00146	0.00302	CcSEcCtD
Morphine—Hyperhidrosis—Temozolomide—malignant glioma	0.00146	0.00302	CcSEcCtD
Morphine—Anorexia—Temozolomide—malignant glioma	0.00144	0.00298	CcSEcCtD
Morphine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00143	0.00295	CcSEcCtD
Morphine—Insomnia—Carmustine—malignant glioma	0.00142	0.00293	CcSEcCtD
Morphine—Paraesthesia—Carmustine—malignant glioma	0.00141	0.00291	CcSEcCtD
Morphine—Dyspnoea—Carmustine—malignant glioma	0.0014	0.00288	CcSEcCtD
Morphine—Somnolence—Carmustine—malignant glioma	0.00139	0.00288	CcSEcCtD
Morphine—CYP2D6—brainstem—malignant glioma	0.00138	0.0153	CbGeAlD
Morphine—OPRM1—brain—malignant glioma	0.00138	0.0153	CbGeAlD
Morphine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00138	0.00285	CcSEcCtD
Morphine—Insomnia—Temozolomide—malignant glioma	0.00137	0.00283	CcSEcCtD
Morphine—Decreased appetite—Carmustine—malignant glioma	0.00136	0.00281	CcSEcCtD
Morphine—Paraesthesia—Temozolomide—malignant glioma	0.00136	0.00281	CcSEcCtD
Morphine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00135	0.00279	CcSEcCtD
Morphine—Dyspnoea—Temozolomide—malignant glioma	0.00135	0.00279	CcSEcCtD
Morphine—Somnolence—Temozolomide—malignant glioma	0.00134	0.00278	CcSEcCtD
Morphine—Constipation—Carmustine—malignant glioma	0.00134	0.00277	CcSEcCtD
Morphine—Pain—Carmustine—malignant glioma	0.00134	0.00277	CcSEcCtD
Morphine—Dyspepsia—Temozolomide—malignant glioma	0.00133	0.00275	CcSEcCtD
Morphine—Decreased appetite—Temozolomide—malignant glioma	0.00131	0.00272	CcSEcCtD
Morphine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00131	0.0027	CcSEcCtD
Morphine—Fatigue—Temozolomide—malignant glioma	0.0013	0.0027	CcSEcCtD
Morphine—Constipation—Temozolomide—malignant glioma	0.00129	0.00267	CcSEcCtD
Morphine—Pain—Temozolomide—malignant glioma	0.00129	0.00267	CcSEcCtD
Morphine—Feeling abnormal—Carmustine—malignant glioma	0.00129	0.00267	CcSEcCtD
Morphine—Gastrointestinal pain—Carmustine—malignant glioma	0.00128	0.00265	CcSEcCtD
Morphine—Feeling abnormal—Temozolomide—malignant glioma	0.00125	0.00258	CcSEcCtD
Morphine—Body temperature increased—Carmustine—malignant glioma	0.00124	0.00256	CcSEcCtD
Morphine—Abdominal pain—Carmustine—malignant glioma	0.00124	0.00256	CcSEcCtD
Morphine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00124	0.00256	CcSEcCtD
Morphine—CYP2D6—telencephalon—malignant glioma	0.00123	0.0136	CbGeAlD
Morphine—Urticaria—Temozolomide—malignant glioma	0.0012	0.00248	CcSEcCtD
Morphine—Body temperature increased—Temozolomide—malignant glioma	0.0012	0.00247	CcSEcCtD
Morphine—Abdominal pain—Temozolomide—malignant glioma	0.0012	0.00247	CcSEcCtD
Morphine—Hypersensitivity—Carmustine—malignant glioma	0.00115	0.00238	CcSEcCtD
Morphine—Asthenia—Carmustine—malignant glioma	0.00112	0.00232	CcSEcCtD
Morphine—Hypersensitivity—Temozolomide—malignant glioma	0.00111	0.0023	CcSEcCtD
Morphine—Asthenia—Temozolomide—malignant glioma	0.00109	0.00224	CcSEcCtD
Morphine—ABCB1—embryo—malignant glioma	0.00108	0.012	CbGeAlD
Morphine—Diarrhoea—Carmustine—malignant glioma	0.00107	0.00221	CcSEcCtD
Morphine—Pruritus—Temozolomide—malignant glioma	0.00107	0.00221	CcSEcCtD
Morphine—Dizziness—Carmustine—malignant glioma	0.00103	0.00214	CcSEcCtD
Morphine—Diarrhoea—Temozolomide—malignant glioma	0.00103	0.00214	CcSEcCtD
Morphine—Dizziness—Temozolomide—malignant glioma	0.001	0.00207	CcSEcCtD
Morphine—Vomiting—Carmustine—malignant glioma	0.000995	0.00206	CcSEcCtD
Morphine—Rash—Carmustine—malignant glioma	0.000987	0.00204	CcSEcCtD
Morphine—Dermatitis—Carmustine—malignant glioma	0.000986	0.00204	CcSEcCtD
Morphine—Headache—Carmustine—malignant glioma	0.00098	0.00203	CcSEcCtD
Morphine—Vomiting—Temozolomide—malignant glioma	0.000962	0.00199	CcSEcCtD
Morphine—ABCB1—retina—malignant glioma	0.000958	0.0106	CbGeAlD
Morphine—Rash—Temozolomide—malignant glioma	0.000954	0.00197	CcSEcCtD
Morphine—Dermatitis—Temozolomide—malignant glioma	0.000953	0.00197	CcSEcCtD
Morphine—Headache—Temozolomide—malignant glioma	0.000947	0.00196	CcSEcCtD
Morphine—Nausea—Carmustine—malignant glioma	0.00093	0.00192	CcSEcCtD
Morphine—Nausea—Temozolomide—malignant glioma	0.000898	0.00186	CcSEcCtD
Morphine—ABCB1—telencephalon—malignant glioma	0.000881	0.00978	CbGeAlD
Morphine—CYP2C8—brain—malignant glioma	0.00083	0.00921	CbGeAlD
Morphine—CYP3A4—central nervous system—malignant glioma	0.000708	0.00785	CbGeAlD
Morphine—CYP2D6—central nervous system—malignant glioma	0.000696	0.00773	CbGeAlD
Morphine—ABCB1—medulla oblongata—malignant glioma	0.000693	0.00768	CbGeAlD
Morphine—CYP2D6—cerebellum—malignant glioma	0.000681	0.00755	CbGeAlD
Morphine—ABCB1—midbrain—malignant glioma	0.000633	0.00702	CbGeAlD
Morphine—ABCB1—spinal cord—malignant glioma	0.000618	0.00685	CbGeAlD
Morphine—CYP2D6—brain—malignant glioma	0.000553	0.00614	CbGeAlD
Morphine—ABCB1—central nervous system—malignant glioma	0.000501	0.00556	CbGeAlD
Morphine—ABCB1—cerebellum—malignant glioma	0.00049	0.00543	CbGeAlD
Morphine—ABCB1—brain—malignant glioma	0.000398	0.00441	CbGeAlD
Morphine—OPRL1—Signaling Pathways—PIK3CA—malignant glioma	5.84e-05	0.000144	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CXCL8—malignant glioma	5.83e-05	0.000144	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP2C18—malignant glioma	5.8e-05	0.000143	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KDR—malignant glioma	5.79e-05	0.000143	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ASMT—malignant glioma	5.78e-05	0.000142	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—IDH1—malignant glioma	5.76e-05	0.000142	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PPARG—malignant glioma	5.74e-05	0.000141	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.72e-05	0.000141	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—AKT1—malignant glioma	5.7e-05	0.00014	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP3—malignant glioma	5.66e-05	0.000139	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TP53—malignant glioma	5.65e-05	0.000139	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CB—malignant glioma	5.65e-05	0.000139	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN2B—malignant glioma	5.61e-05	0.000138	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SPHK1—malignant glioma	5.58e-05	0.000137	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—F2—malignant glioma	5.57e-05	0.000137	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—FN1—malignant glioma	5.57e-05	0.000137	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL2—malignant glioma	5.57e-05	0.000137	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	5.57e-05	0.000137	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TERT—malignant glioma	5.55e-05	0.000137	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.52e-05	0.000136	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—BAD—malignant glioma	5.51e-05	0.000136	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP2C18—malignant glioma	5.46e-05	0.000134	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NOTCH1—malignant glioma	5.45e-05	0.000134	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTK2—malignant glioma	5.45e-05	0.000134	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—BCAN—malignant glioma	5.44e-05	0.000134	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCL8—malignant glioma	5.43e-05	0.000134	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PDGFB—malignant glioma	5.42e-05	0.000133	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—FGFR1—malignant glioma	5.39e-05	0.000133	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	5.39e-05	0.000133	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTT1—malignant glioma	5.38e-05	0.000132	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CB—malignant glioma	5.36e-05	0.000132	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HES1—malignant glioma	5.35e-05	0.000132	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CD80—malignant glioma	5.34e-05	0.000132	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CG—malignant glioma	5.33e-05	0.000131	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—APC—malignant glioma	5.33e-05	0.000131	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NCOR1—malignant glioma	5.32e-05	0.000131	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTGS2—malignant glioma	5.31e-05	0.000131	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HIF1A—malignant glioma	5.31e-05	0.000131	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CAV1—malignant glioma	5.31e-05	0.000131	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGF—malignant glioma	5.27e-05	0.00013	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—RAF1—malignant glioma	5.25e-05	0.000129	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTPN11—malignant glioma	5.24e-05	0.000129	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CD—malignant glioma	5.23e-05	0.000129	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—IL2—malignant glioma	5.19e-05	0.000128	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CAV1—malignant glioma	5.13e-05	0.000126	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CB—malignant glioma	5.13e-05	0.000126	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PDGFRA—malignant glioma	5.1e-05	0.000125	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KDR—malignant glioma	5.08e-05	0.000125	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS1—malignant glioma	5.04e-05	0.000124	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.02e-05	0.000124	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—BRAF—malignant glioma	5.01e-05	0.000123	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—AKT1—malignant glioma	4.98e-05	0.000123	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—AKT1—malignant glioma	4.98e-05	0.000123	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SPP1—malignant glioma	4.95e-05	0.000122	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCL8—malignant glioma	4.93e-05	0.000121	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—FN1—malignant glioma	4.89e-05	0.00012	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—F2—malignant glioma	4.89e-05	0.00012	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT2—malignant glioma	4.88e-05	0.00012	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—EGFR—malignant glioma	4.86e-05	0.00012	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CG—malignant glioma	4.83e-05	0.000119	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—BAD—malignant glioma	4.83e-05	0.000119	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NOTCH1—malignant glioma	4.78e-05	0.000118	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AKT1—malignant glioma	4.77e-05	0.000117	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL2—malignant glioma	4.71e-05	0.000116	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TERT—malignant glioma	4.69e-05	0.000115	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CD—malignant glioma	4.69e-05	0.000115	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTT1—malignant glioma	4.69e-05	0.000115	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—BCHE—malignant glioma	4.69e-05	0.000115	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CD80—malignant glioma	4.69e-05	0.000115	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—APC—malignant glioma	4.68e-05	0.000115	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CG—malignant glioma	4.68e-05	0.000115	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PPARG—malignant glioma	4.67e-05	0.000115	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—PIK3CA—malignant glioma	4.64e-05	0.000114	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTEN—malignant glioma	4.63e-05	0.000114	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SLC5A5—malignant glioma	4.63e-05	0.000114	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGF—malignant glioma	4.62e-05	0.000114	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTPN11—malignant glioma	4.59e-05	0.000113	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—KRAS—malignant glioma	4.59e-05	0.000113	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PDGFB—malignant glioma	4.58e-05	0.000113	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CB—malignant glioma	4.56e-05	0.000112	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FGFR1—malignant glioma	4.56e-05	0.000112	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	4.55e-05	0.000112	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTGS2—malignant glioma	4.52e-05	0.000111	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—FGF2—malignant glioma	4.49e-05	0.000111	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HIF1A—malignant glioma	4.49e-05	0.00011	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTT1—malignant glioma	4.42e-05	0.000109	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—BRAF—malignant glioma	4.4e-05	0.000108	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS1—malignant glioma	4.39e-05	0.000108	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—IDH2—malignant glioma	4.38e-05	0.000108	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.38e-05	0.000108	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.34e-05	0.000107	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CAV1—malignant glioma	4.34e-05	0.000107	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KDR—malignant glioma	4.29e-05	0.000106	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT2—malignant glioma	4.28e-05	0.000105	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—EGFR—malignant glioma	4.26e-05	0.000105	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CD—malignant glioma	4.25e-05	0.000105	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PIK3CA—malignant glioma	4.22e-05	0.000104	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MDM2—malignant glioma	4.2e-05	0.000103	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RAF1—malignant glioma	4.19e-05	0.000103	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ERBB2—malignant glioma	4.14e-05	0.000102	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS1—malignant glioma	4.14e-05	0.000102	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—F2—malignant glioma	4.13e-05	0.000102	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FN1—malignant glioma	4.13e-05	0.000102	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.12e-05	0.000101	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CD—malignant glioma	4.11e-05	0.000101	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CB—malignant glioma	4.09e-05	0.000101	CbGpPWpGaD
Morphine—ABCB1—Metabolism—BCHE—malignant glioma	4.08e-05	0.000101	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—BAD—malignant glioma	4.08e-05	0.0001	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—PIK3CA—malignant glioma	4.07e-05	0.0001	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NOTCH1—malignant glioma	4.04e-05	9.95e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC5A5—malignant glioma	4.03e-05	9.93e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—KRAS—malignant glioma	4.03e-05	9.91e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CD80—malignant glioma	3.96e-05	9.75e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—APC—malignant glioma	3.95e-05	9.73e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CG—malignant glioma	3.95e-05	9.73e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTEN—malignant glioma	3.94e-05	9.7e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—FGF2—malignant glioma	3.94e-05	9.69e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCL8—malignant glioma	3.93e-05	9.67e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGF—malignant glioma	3.91e-05	9.62e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTPN11—malignant glioma	3.88e-05	9.56e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—BCHE—malignant glioma	3.85e-05	9.47e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC5A5—malignant glioma	3.8e-05	9.36e-05	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AKT1—malignant glioma	3.79e-05	9.34e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.78e-05	9.32e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—IDH1—malignant glioma	3.77e-05	9.27e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CASP3—malignant glioma	3.76e-05	9.25e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL2—malignant glioma	3.75e-05	9.24e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTP1—malignant glioma	3.73e-05	9.18e-05	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.72e-05	9.15e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—BRAF—malignant glioma	3.72e-05	9.15e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CB—malignant glioma	3.7e-05	9.12e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PIK3CA—malignant glioma	3.7e-05	9.1e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MDM2—malignant glioma	3.68e-05	9.07e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RAF1—malignant glioma	3.67e-05	9.04e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—malignant glioma	3.67e-05	9.03e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SPHK1—malignant glioma	3.65e-05	8.97e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ERBB2—malignant glioma	3.63e-05	8.94e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CAT—malignant glioma	3.63e-05	8.94e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT2—malignant glioma	3.62e-05	8.9e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EGFR—malignant glioma	3.6e-05	8.86e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CB—malignant glioma	3.58e-05	8.82e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.57e-05	8.79e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MMP9—malignant glioma	3.55e-05	8.74e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTEN—malignant glioma	3.53e-05	8.69e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CD—malignant glioma	3.47e-05	8.55e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT1—malignant glioma	3.45e-05	8.48e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL8—malignant glioma	3.44e-05	8.48e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CA—malignant glioma	3.44e-05	8.47e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NCOR1—malignant glioma	3.43e-05	8.44e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—KRAS—malignant glioma	3.4e-05	8.37e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FGF2—malignant glioma	3.33e-05	8.19e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT1—malignant glioma	3.33e-05	8.19e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CASP3—malignant glioma	3.3e-05	8.11e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL2—malignant glioma	3.29e-05	8.1e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CA—malignant glioma	3.27e-05	8.04e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTP1—malignant glioma	3.25e-05	8e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTEN—malignant glioma	3.2e-05	7.88e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—malignant glioma	3.19e-05	7.85e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CAT—malignant glioma	3.16e-05	7.78e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—STAT3—malignant glioma	3.16e-05	7.77e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CA—malignant glioma	3.13e-05	7.69e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MMP9—malignant glioma	3.11e-05	7.67e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MDM2—malignant glioma	3.11e-05	7.66e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RAF1—malignant glioma	3.1e-05	7.64e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTEN—malignant glioma	3.1e-05	7.62e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ERBB2—malignant glioma	3.07e-05	7.55e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTP1—malignant glioma	3.06e-05	7.54e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CB—malignant glioma	3.03e-05	7.46e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT1—malignant glioma	3.02e-05	7.44e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NCOR1—malignant glioma	2.99e-05	7.35e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CAT—malignant glioma	2.98e-05	7.34e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MYC—malignant glioma	2.93e-05	7.22e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL8—malignant glioma	2.91e-05	7.16e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTT1—malignant glioma	2.89e-05	7.11e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGFR—malignant glioma	2.87e-05	7.07e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NCOR1—malignant glioma	2.81e-05	6.93e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT1—malignant glioma	2.81e-05	6.92e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—malignant glioma	2.8e-05	6.89e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CAV1—malignant glioma	2.79e-05	6.88e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CASP3—malignant glioma	2.79e-05	6.86e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL2—malignant glioma	2.78e-05	6.85e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CA—malignant glioma	2.78e-05	6.84e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—STAT3—malignant glioma	2.77e-05	6.82e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KRAS—malignant glioma	2.71e-05	6.68e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS1—malignant glioma	2.71e-05	6.66e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.67e-05	6.57e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AKT1—malignant glioma	2.67e-05	6.57e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP9—malignant glioma	2.63e-05	6.48e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTEN—malignant glioma	2.62e-05	6.44e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MYC—malignant glioma	2.57e-05	6.33e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT1—malignant glioma	2.55e-05	6.29e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CG—malignant glioma	2.55e-05	6.27e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGFR—malignant glioma	2.52e-05	6.2e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—BCHE—malignant glioma	2.52e-05	6.19e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CA—malignant glioma	2.49e-05	6.13e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.49e-05	6.12e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPARG—malignant glioma	2.46e-05	6.05e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CAV1—malignant glioma	2.43e-05	5.99e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—malignant glioma	2.41e-05	5.93e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KRAS—malignant glioma	2.38e-05	5.85e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—malignant glioma	2.36e-05	5.82e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—STAT3—malignant glioma	2.34e-05	5.76e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CAV1—malignant glioma	2.29e-05	5.65e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKT1—malignant glioma	2.27e-05	5.59e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CA—malignant glioma	2.26e-05	5.56e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CD—malignant glioma	2.24e-05	5.51e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CG—malignant glioma	2.22e-05	5.46e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CA—malignant glioma	2.18e-05	5.38e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MYC—malignant glioma	2.18e-05	5.35e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPARG—malignant glioma	2.14e-05	5.27e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGFR—malignant glioma	2.13e-05	5.24e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—malignant glioma	2.11e-05	5.2e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.09e-05	5.14e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT1—malignant glioma	2.04e-05	5.01e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPARG—malignant glioma	2.02e-05	4.96e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KRAS—malignant glioma	2.01e-05	4.95e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTP1—malignant glioma	2e-05	4.93e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.95e-05	4.8e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CD—malignant glioma	1.95e-05	4.8e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CAT—malignant glioma	1.95e-05	4.8e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—malignant glioma	1.93e-05	4.76e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CA—malignant glioma	1.85e-05	4.54e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKT1—malignant glioma	1.84e-05	4.54e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NCOR1—malignant glioma	1.84e-05	4.53e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.84e-05	4.52e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—malignant glioma	1.79e-05	4.4e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT1—malignant glioma	1.78e-05	4.39e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CB—malignant glioma	1.7e-05	4.18e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTEN—malignant glioma	1.69e-05	4.15e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—malignant glioma	1.68e-05	4.14e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.6e-05	3.94e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—malignant glioma	1.59e-05	3.91e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT1—malignant glioma	1.51e-05	3.71e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CAV1—malignant glioma	1.5e-05	3.69e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTEN—malignant glioma	1.47e-05	3.61e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTEN—malignant glioma	1.38e-05	3.41e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.37e-05	3.36e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPARG—malignant glioma	1.32e-05	3.25e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.2e-05	2.96e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.19e-05	2.93e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.05e-05	2.58e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.04e-05	2.55e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CA—malignant glioma	1.04e-05	2.55e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CA—malignant glioma	9.76e-06	2.4e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKT1—malignant glioma	9.71e-06	2.39e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTEN—malignant glioma	9.05e-06	2.23e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKT1—malignant glioma	8.46e-06	2.08e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKT1—malignant glioma	7.97e-06	1.96e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CA—malignant glioma	6.38e-06	1.57e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKT1—malignant glioma	5.21e-06	1.28e-05	CbGpPWpGaD
